Burcon NutraScience Corporation
Burcon Engages Financial Advisor
Vancouver, Canada, November 6 (ots/PRNewswire)
Burcon NutraScience Corporation (TSX-V: BU) announces today the appointment of BMO Capital Markets to act as exclusive financial advisor to Burcon in connection with a process to identify and pursue strategic alternatives for the commercialization of its innovative food technology.
In engaging BMO Capital Markets, Burcon is initiating an extensive review of alternative strategies for maximizing shareholder value arising from Burcon's intellectual property portfolio including the recently announced soy protein isolate technology and CLARISOY(TM).
Mr. Johann F. Tergesen, Burcon's President and C.O.O. noted "The goal of this engagement is simple: maximizing the value of Burcon and Burcon's intellectual property portfolio. We have been working with BMO Capital Markets and their food and agribusiness teams in Toronto and Chicago, who understand the potential of our company and have formidable credentials in the agribusiness and food industries. We have many opportunities in front of us and we are excited to have BMO Capital Markets helping us to chart a course of action."
About Burcon NutraScience
Burcon is a research and development company developing a portfolio of composition, application, and process patents around its plant protein extraction and purification technology. The goal of Burcon's research is to develop its patented process to utilize inexpensive oilseed meals for the production of purified plant proteins that exhibit valuable nutritional, functional or nutraceutical profiles. Burcon, in conjunction with Archer Daniels Midland, is currently focusing its efforts on developing the world's first commercial canola proteins, Puratein(R) and Supertein(TM). Canola, recognized for its nutritional qualities, is the second-largest oilseed crop in the world after soybeans. Burcon's goal is to develop Puratein(R) and Supertein(TM) to participate with soy, dairy, and egg proteins in the expanding multi-billion-dollar protein ingredient market, with potential uses in prepared foods, nutritional supplements, and personal care products.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President & Chief Operating OfficerThe TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal," "intend," "believes" and "potential" and similar expressions, generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.
For further information: Jade Cheng, Chief Financial Officer, Burcon NutraScience Corporation, +1-604-733-0896, 888-408-7960 toll-free, jcheng@burcon.ca, http://www.burcon.ca; AXINO AG, Sven Olsson, Investor Relations Europe, Konigstrasse 26 70173 Stuttgart, Germany, Tel. +49-711-25-35-92-30, Fax +49-711-25-35-92-33, olsson@axino.de, http://www.burcon.net/
Contact:
For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, +1-604-733-0896, 888-408-7960 toll-free,
jcheng@burcon.ca; AXINO AG, Sven Olsson, Investor Relations Europe,
Konigstrasse 26 70173 Stuttgart, Germany, Tel. +49-711-25-35-92-30,
Fax +49-711-25-35-92-33, olsson@axino.de